|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/18/15 Emmaus Life Sciences, Inc. 10-Q/A 3/31/15 55:7.2M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-Q/A Amendment to Quarterly Report HTML 31K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 22K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 22K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
35: R1 Document And Entity Information HTML 39K
25: R2 Condensed Consolidated Statements of Operations HTML 94K
33: R3 Condensed Consolidated Balance Sheets HTML 113K
37: R4 Condensed Consolidated Balance Sheets HTML 44K
[Parenthetical]
50: R5 Condensed Consolidated Statements of Cash Flows HTML 111K
26: R6 Condensed Consolidated Statements of Stockholders' HTML 68K
Deficit
32: R7 Nature of Operations HTML 32K
22: R8 Summary of Significant Accounting Policies HTML 85K
16: R9 Discontinued Operations HTML 63K
51: R10 Convertible Debt and Equity Financings HTML 51K
39: R11 Derivative Liabilities HTML 27K
38: R12 Stockholders' Deficit HTML 156K
43: R13 Related Party Transactions HTML 46K
44: R14 Loss Per Share HTML 106K
42: R15 Commitments and Contingent Liabilities HTML 57K
45: R16 Summary of Significant Accounting Policies HTML 142K
(Policies)
34: R17 Summary of Significant Accounting Policies HTML 45K
(Tables)
36: R18 Discontinued Operations (Tables) HTML 59K
41: R19 Convertible Debt and Equity Financings (Tables) HTML 43K
55: R20 Derivative Liabilities (Tables) HTML 24K
47: R21 Stockholders' Deficit (Tables) HTML 137K
28: R22 Loss Per Share (Tables) HTML 102K
40: R23 Commitments and Contingent Liabilities (Tables) HTML 40K
30: R24 Summary of Significant Accounting Policies HTML 27K
(Details)
14: R25 Summary of Significant Accounting Policies HTML 41K
(Details 1)
48: R26 Summary of Significant Accounting Policies HTML 46K
(Details Textual)
52: R27 Discontinued Operations (Details) HTML 69K
19: R28 Convertible Debt and Equity Financings (Details) HTML 61K
18: R29 Convertible Debt and Equity Financings (Details HTML 37K
Textual)
20: R30 Derivative Liabilities (Details) HTML 27K
21: R31 Derivative Liabilities (Details Textual) HTML 42K
23: R32 Stockholders' Deficit (Details) HTML 42K
13: R33 Stockholders' Deficit (Details 1) HTML 46K
46: R34 Stockholders' Deficit (Details 2) HTML 130K
27: R35 Stockholders' Deficit (Details 3) HTML 48K
29: R36 Stockholders' Deficit (Details 4) HTML 62K
15: R37 Stockholders' Deficit (Details Textual) HTML 246K
54: R38 Related Party Transactions (Details Textual) HTML 211K
11: R39 Loss Per Share (Details) HTML 100K
24: R40 Commitments and Contingent Liabilities (Details) HTML 58K
49: R41 Commitments and Contingent Liabilities (Details HTML 58K
Textual)
53: XML IDEA XML File -- Filing Summary XML 79K
12: EXCEL IDEA Workbook of Financial Reports XLSX 139K
17: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.21M
5: EX-101.INS XBRL Instance -- cnso-20150331 XML 1.80M
7: EX-101.CAL XBRL Calculations -- cnso-20150331_cal XML 132K
8: EX-101.DEF XBRL Definitions -- cnso-20150331_def XML 1.00M
9: EX-101.LAB XBRL Labels -- cnso-20150331_lab XML 1.17M
10: EX-101.PRE XBRL Presentations -- cnso-20150331_pre XML 1.09M
6: EX-101.SCH XBRL Schema -- cnso-20150331 XSD 227K
31: ZIP XBRL Zipped Folder -- 0001144204-15-031936-xbrl Zip 167K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1 to
FORM 10-Q
(Mark One)
x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended March 31, 2015
¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from __________________ to ______________________.
Commission file number 001-35527
CNS Response, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 87-0419387 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) |
85 Enterprise, Suite 410
(Address of principal executive offices) (Zip Code)
(949) 420-4400
(Registrant’s telephone number, including area code)
(Former name, former address, former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ¨ | Accelerated filer | ¨ |
| Non-accelerated filer | ¨ (Do not check if smaller reporting company) | Smaller reporting company | x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨ No x
As of May 15, 2015, the issuer had 101,667,409 shares of common stock, par value $.001 per share, issued and outstanding.
C:
EXPLANATORY NOTE
The sole purpose of this amendment to our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2015, originally filed with the Securities and Exchange Commission on May 15, 2015 (the “Original Form 10-Q”), is to furnish the exhibits required by Item 601(b)(101) (Interactive Data File) of Regulation S-K.
No other changes have been made to the Original Form 10-Q and the Original Form 10-Q has not been updated to reflect events occurring subsequent to the original filing date.
C:
Item 6. Exhibits
The following exhibits are filed as part of this report or incorporated by reference herein:
|
Exhibit Number |
Exhibit Title | |
| 31.1 | Certification of Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002. | |
| 31.2 | Certification of Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002. | |
| 32.1 | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002. | |
| 101.INS | XBRL Instance Document | |
| 101.SCH | XBRL Taxonomy Extension Schema | |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase | |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase | |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase | |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
C:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CNS Response, Inc. | |||
| Date: May 18, 2015 | /s/ George Carpenter | ||
| By: | George Carpenter | ||
| Its: | Chief Executive Officer | ||
| (Principal Executive Officer) | |||
| /s/ Paul Buck | |||
| By: | Paul Buck | ||
| Its: | Chief Financial Officer | ||
| (Principal Financial Officer) | |||
C:
| This ‘10-Q/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/18/15 | |||
| 5/15/15 | 10-Q | |||
| For Period end: | 3/31/15 | 10-Q | ||
| List all Filings | ||||